US OptionsDetailed Quotes

BEAM240816C30000

Watchlist

3.35
+0.15+4.69%

15min DelayClose Jul 30 16:00 ET

3.35High3.35Low

Beam Therapeutics Stock Discussion

ClydePeternuts

Jul 17 03:06

Cathie Wood and Ark Invest's trade activity from 2024/07/16

Buys🟢\\ $Beam Therapeutics(BEAM.US)$ $Oklo Inc(OKLO.US)$
Sells🔴\\ $Zoom Video Communications(ZM.US)$ $Trimble(TRMB.US)$ $Twist Bioscience(TWST.US)$ $UiPath(PATH.US)$

frankinglily

May 14 03:38

How does the biotech ecosystem support advancements in personalized medicine & genomics?
• Editing Genes | $CRISPR Therapeutics(CRSP.US)$ , $Intellia Therapeutics(NTLA.US)$ , $Beam Therapeutics(BEAM.US)$ , $Verve Therapeutics(VERV.US)$ , $Editas Medicine(EDIT.US)$
• Creating Therapies | $Prime Medicine(PRME.US)$ , $Sana Biotechnology(SANA.US)$
• Building DNA | $Twist Bioscience(TWST.US)$ , $Ginkgo Bioworks(DNA.US)$ , $Pacific Biosciences of California(PACB.US)$ , $Illumina(ILMN.US)$
• Dis...

PaulG

Feb 27 14:10

$Beam Therapeutics(BEAM.US)$ Will double to 90 dollars 💸 💵 💲

Kevin Travers

Feb 27 10:02

Columns Biotechnology Stocks Climbing on Earnings and Test Results: What to Watch

$Viking Therapeutics (VKTX.US)$skyrocketed 77% after positive drug trial news Tuesday, leading to what proved to be a strong morning for pharmaceutical stocks.
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...

Moomoo AI

Dec 14, 2023 05:35

Beam Therapeutics' CEO, John Evans showed confidence in Ms. Shaw's ability to turn scientific innovations into commercial treatments. Shaw recognizes Beam's groundbreaking work in genetic medicine and gene editing, predicting major clinical milestones ahead thanks to the company's comprehensive platform and capabilities.

Press Release: Beam Therapeutics Appoints Biotech Executive Christi Shaw to Its Board of Directors

Chatterbox Moo

Nov 27, 2023 04:15

Columns Gene Editing: Is This "Turning Point in Medicine" a Potential Source of Blockbuster Revenue?

The first treatment based on CRISPR technology is poised to win FDA approval next month, offering hope to patients and opportunities to investors.
"A turning point in medicine"
Scientists have made significant progress in treating thousands of illnesses over the years, but finding cures for rare and deadly diseases remains a significant challenge. While treatments for inherited conditions like sickle cell...

Moomoo AI

Nov 1, 2023 14:59

Analysts convey bullish views on the company's prospects, with reduced estimated losses and upgraded revenue estimates. However, issues like dilutive stock issuance hint at potential risks.

New Forecasts: Here's What Analysts Think The Future Holds For Beam Therapeutics Inc. (NASDAQ:BEAM)

Trytosaveabit

Oct 31, 2023 05:37

A bit more

$Beam Therapeutics(BEAM.US)$ Beam Therapeutics to Sell Rights in Verve Licensing Deal to Lilly for $250M Upfront
Dow Jones· 4 mins ago

Trytosaveabit

Oct 31, 2023 05:13

Nice!

$Beam Therapeutics(BEAM.US)$

Trytosaveabit

Oct 31, 2023 05:04

Update

$Beam Therapeutics(BEAM.US)$ Press Release: Beam Announces Agreement for Lilly to Acquire Beam's Opt-In Rights to Verve Therapeutics' Base Editing Programs for Cardiovascular Disease
Dow Jones· 2 mins ago

No comment yet